APA (7th ed.) Citation

DA, H., MS, A., JE, M., SES, L., MS, A., S, G., . . . S, M. (2024). Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 42(4), 441. https://doi.org/10.1200/JCO.23.01838

Chicago Style (17th ed.) Citation

DA, Haas-Kogan, et al. "Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 42, no. 4 (2024): 441. https://doi.org/10.1200/JCO.23.01838.

MLA (9th ed.) Citation

DA, Haas-Kogan, et al. "Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 42, no. 4, 2024, p. 441, https://doi.org/10.1200/JCO.23.01838.